Oncology Nurse from The Cancer Institute of New Jersey Shares Expertise on Breast Cancer

Symposium to Focus on “Top 10 Questions Women Have Following First Line Therapy”
April 25, 2011

New Brunswick, N.J.– Knowledge is power. This sentiment is echoed in the work of today’s nurses and their pursuit of both clinical knowledge and technical expertise. Nurses from The Cancer Institute of New Jersey (CINJ) and throughout the country will be doing their part to contribute to the art of nursing when presenting at the Oncology Nursing Society’s 36th Annual Congress being held this week in Boston. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

The conference features panel discussions, presentations and poster sessions on site-specific cancers, prevention, detection, symptom management, treatment advances and other topics dedicated to oncology nursing. One such symposium will be chaired by Jacquelyn Lauria, RN, MS, APN, AOCNP, an advanced practice nurse (APN) at CINJ, who will present the “Top 10 Questions of Women with Metastatic Breast Cancer Following First Line Therapy.”

The goal of the discussion is to strengthen the knowledge of oncology nurses involved in the care of patients with pretreated breast cancer.  The focus will be on therapeutic options, side-effect management, and health-literate patient education strategies.

As an APN with expertise in breast cancer, Lauria is involved in treatment, research and education at CINJ. She also participates in the training of oncology nurses at CINJ’s Network hospitals. “I feel it is important for practitioners to be well-versed, not only in their direct nursing care, but also in patient education. If nurses can anticipate patients’ questions and answer them effectively, it will enhance treatment outcomes and patient satisfaction,” stated Lauria.

The Oncology Nursing Society’s 36th Annual Congress is open to registered participants only.

About The Cancer Institute of New Jersey
The Cancer Institute of New Jersey ( is the state’s first and only National Cancer Institute-designated Comprehensive Cancer Center dedicated to improving the detection, treatment and care of patients with cancer, and serving as an education resource for cancer prevention. CINJ’s physician-scientists engage in translational research, transforming their laboratory discoveries into clinical practice, quite literally bringing research to life.  To make a tax-deductible gift to support CINJ, call 732-235-8614 or visit CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

The CINJ Network is comprised of hospitals throughout the state and provides the highest quality cancer care and rapid dissemination of important discoveries into the community. Flagship Hospital: Robert Wood Johnson University Hospital. System Partner: Meridian Health (Jersey Shore University Medical Center, Ocean Medical Center, Riverview Medical Center, Southern Ocean Medical Center, and Bayshore Community Hospital). Major Clinical Research Affiliate Hospitals: Carol G. Simon Cancer Center at Morristown Memorial Hospital, Carol G. Simon Cancer Center at Overlook Hospital, and Cooper University Hospital. Affiliate Hospitals: CentraState Healthcare System, JFK Medical Center, Mountainside Hospital, Raritan Bay Medical Center, Robert Wood Johnson University Hospital Hamilton (CINJ Hamilton), Somerset Medical Center, The University Hospital/UMDNJ-New Jersey Medical School*, and University Medical Center at Princeton. *Academic Affiliate

Michele Fisher


precision medicine at Rutgers Cancer Institute







Donate Now








Proud member of
Big Ten Cancer Research Consortium



Rutgers Health